Andrea McCollum

Government of the United States of America - Division of High Consequence Pathogens and Pathology

Atlanta, GA

United States

Government of the United States of America - Centers for Disease Control and Prevention (CDC)

1600 Clifton Rd., NE

Atlanta, GA 30333

United States

  • Government of the United States of America - Division of High Consequence Pathogens and Pathology

  • Government of the United States of America - Centers for Disease Control and Prevention (CDC)

SCHOLARLY PAPERS

5

DOWNLOADS

621

TOTAL CITATIONS

7

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Mpox in the Democratic Republic of Congo: Analysis of National Epidemiological and Laboratory Surveillance Data, 2010 - 2023

Number of pages: 30 Posted: 19 Sep 2024
Eugene Bangwen, Ruth Diavita, Elise De Vos, Emmanuel Hasivirwe Vakaniaki, Sabin S. Nundu, Annie Mutombo, Felix Mulangu, Aaron Aruna Abedi, Emile Malembi, Thierry Kalonji, Cris Kacita, Eddy Kinganda-Lusamaki, Tony Wawina-Bokalanga, Isabel Brosius, Christophe Van Dijck, Emmanuel Bottieau, Koen Vercauteren, Adrienne Amuri-Aziza, Jean-Claude Makangara-Cigolo, Elisabeth Muyamuna, Elisabeth Pukuta, Beatrice Nguete, Didine Kaba, Joelle Kabamba, Christine Hughes, Olivier Tshiani Mbaya, Anne W. Rimoin, Nicole A. Hoff, Jason Kindrachuk, Martine Peeters, Nicola Low, Andrea McCollum, Robert Shongo, Daniel Bamuleka Mukadi, Jean-Jacques Muyembe-Tamfum, Steve Ahuka-Mundeke, Laurens Liesenborghs and Placide Mbala
Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, University of Antwerp - Department of Clinical Sciences, University of Antwerp - Department of Clinical Sciences, University of Antwerp - Department of Clinical Sciences, University of Antwerp - Department of Clinical Sciences, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Kinshasa School of Public Health, Kinshasa School of Public Health, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), University of California, Los Angeles (UCLA) - Department of Epidemiology, University of California, Los Angeles (UCLA) - Department of Epidemiology, University of Manitoba - Department of Infectious Diseases and Medical Microbiology, University of Montpellier, University of Bern - Institute of Social and Preventive Medicine, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Democratic Republic of Congo - Ministry of Health, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, National Multisectoral Committee for Ebola Response, KU Leuven - Rega Institute for Medical Research and Institut National de Recherche Biomédicale
Downloads 329 (184,620)

Abstract:

Loading...

Mpox, Monkeypox virus, Incidence, Surveillance, Mpox Confirmatory Testing, DR Congo

2.

Serological Responses to the Mva-Based Jynneos Monkeypox Vaccine in a Cohort of Participants from the Democratic Republic of Congo

Number of pages: 15 Posted: 07 Oct 2022
Lalita Priyamvada, William C. Carson, Eddy Ortega, Terese Navarra, Stephanie Tran, Todd G. Smith, Elisabeth Pukuta, Elisabeth Muyamuna, Joelle Kabamba, Beatrice U. Nguete, Toutou Likafi, Gaston Kokola, Robert Shongo Lushima, Jean Jacques Muyembe-Tamfum, Emile Okitolonda-Wemakoy, Didine K. Kaba, Benjamin P. Monroe, Andrea McCollum, Brett Petersen, Panayampalli S. Satheshkumar and Michael Townsend
Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Centers for Disease Control and Prevention, Democratic Republic of the Congo, Kinshasa School of Public Health, Kinshasa School of Public Health, Kinshasa School of Public Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo, Kinshasa School of Public Health, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC) and Government of the United States of America - Centers for Disease Control and Prevention (CDC)
Downloads 85 (588,859)

Abstract:

Loading...

JYNNEOS, MVA, Monkeypox, Orthopoxvirus, Serology, Antibody, Immunogenicity

3.

Risk Factors for New Neurological Diagnoses in Hospitalized COVID-19 Patients: A Case-Control Study in New York City

Downloads 85 (588,859)

Risk Factors for New Neurological Diagnoses in Hospitalized COVID-19 Patients: A Case-Control Study in New York City

Number of pages: 32 Posted: 04 Jan 2022 Last Revised: 10 Jan 2022
Kiran T. Thakur, Victoria T. Chu, Christine Hughes, Carla Y. Kim, Shannon Fleck-Dardarian, Catherine Barrett, Elizabeth Matthews, Alanna Balbi, Amanda Bilski, Mashina Chomba, Ori Lieberman, Samuel Jacobsen, Sachin Agarwal, David Roh, Soojin Park, Vivian Ssonko, Wendy Silver, Wendy Vargas, Andrew Geneslaw, Michelle Bell, Brandon Waters, Agam Rao, Jan Claassen, Amelia Boehme, Joshua Willey, Mitchell S.V. Elkind, Magdalena Sobieszczyk, Jason Zucker, Andrea McCollum and James J. Sejvar
Cornell University - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Cornell University - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), University of Colorado, Aurora - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Irving Medical Center, Columbia University, College of Physicians & Surgeons, Department of Pediatrics, Columbia University - Department of Neurology, University of North Carolina (UNC) at Chapel Hill - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Columbia University - Division of Hospital and Critical Care Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Department of Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Division of Infectious Diseases, Government of the United States of America - Division of High Consequence Pathogens and Pathology and Government of the United States of America - Division of High Consequence Pathogens and Pathology
Downloads 67 (682,761)

Abstract:

Loading...

COVID-19, SARS-CoV-2, neurological diagnoses, encephalopathy

Risk Factors for New Neurological Diagnoses in Hospitalized COVID-19 Patients: A Case-Control Study in New York City

Number of pages: 28 Posted: 06 Jan 2022
Kiran T. Thakur, Victoria T. Chu, Christine Hughes, Carla Y. Kim, Shannon Fleck-Dardarian, Katherine Barrett, Elizabeth Matthews, Alanna Balbi, Amanda Bilski, Mashina Chomba, Ori Lieberman, Samuel Jacobsen, Sachin Agarwal, David Roh, Soojin Park, Vivian Ssonko, Wendy Silver, Wendy Vargas, Andrew Geneslaw, Michelle Bell, Brandon Waters, Agam Rao, Jan Claassen, Amelia Boehme, Joshua Willey, Mitchell S.V. Elkind, Magdalena Sobieszczyk, Jason Zucker, Andrea McCollum and James J. Sejvar
Cornell University - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Cornell University - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), University of Colorado, Aurora - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Irving Medical Center, Columbia University, College of Physicians & Surgeons, Department of Pediatrics, Columbia University - Department of Neurology, University of North Carolina (UNC) at Chapel Hill - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Columbia University - Division of Hospital and Critical Care Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Department of Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Division of Infectious Diseases, Government of the United States of America - Division of High Consequence Pathogens and Pathology and Government of the United States of America - Division of High Consequence Pathogens and Pathology
Downloads 18 (1,085,547)

Abstract:

Loading...

COVID-19, SARS-CoV-2, neurological diagnoses, Encephalopathy

4.

Clinical and Epidemiologic Findings from Enhanced Monkeypox Surveillance in Tshuapa Province, Democratic Republic of the Congo During 2011–2015

Number of pages: 27 Posted: 30 Oct 2020
Erin Rachel Whitehouse, Jesse Bonwitt, Christine M. Hughes, Robert Shongo Lushima, Toutou Likafi, Beatrice Nguete, Joelle Kabamba, Benjamin Monroe, Jeffrey B. Doty, Yoshinori Nakazawa, Inger Damon, Jean Malekani, Whitni Davidson, Kimberly Wilkins, Yu Li, Kay W. Radford, Scott Schmid, Elisabeth Pukuta, Elisabeth Muyamuna, Stomy Karhemere, Jean-Jacques Muyembe Tamfum, Emile Wemakoy Okitolonda, Andrea McCollum and Mary G. Reynolds
Government of the United States of America - Epidemic Intelligence Service (EIS), Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Ministère de la Santé Publique, Kinshasa, Ecole de Santé Publique de Kinshasa, Ecole de Santé Publique de Kinshasa, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Ecole de Santé Publique de Kinshasa, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Government of the United States of America - Division of Viral Diseases, Government of the United States of America - Division of Viral Diseases, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Ecole de Santé Publique de Kinshasa, Government of the United States of America - Division of High Consequence Pathogens and Pathology and Government of the United States of America - Division of High Consequence Pathogens and Pathology
Downloads 68 (665,888)
Citation 1

Abstract:

Loading...

Monkeypox, Monkeypox virus, Surveillance, Democratic Republic of the Congo, Orthopoxvirus

5.

Human Monkeypox – After 40 Years, an Unintended Consequence of Smallpox Eradication

Number of pages: 12 Posted: 19 Feb 2020
Karl Simpson, David Heyman, Steven Bland, Colin Brown, W. John Edmunds, Jesper Elsgaard, Paul Fine, Hubertus Hochrein, Nicole A. Hoff, Andrew Green, Chikwe Ihekweazu, Terry Jones, Swaib A. Lule, Jane Maclennan, Andrea McCollum, Barbara Mühlemann, Emily Nightingale, Dimie Ogoina, Adesola Yinka-Ogunleye, Brett Petersen, Jacqueline Powell, Ollie Quantick, Anne W. Rimoin, David Ulaeato and Andy Wapling
JKS Bioscience Limited, London School of Hygiene & Tropical Medicine, Government of the United Kingdom - Royal Navy, Public Health England Colindale, London School of Hygiene & Tropical Medicine, Bavarian Nordic A/S, London School of Hygiene & Tropical Medicine, Bavarian Nordic GmbH, University of California, Los Angeles (UCLA) - Jonathan and Karin Fielding School of Public Health, Royal Centre of Defence Medicine, Nigeria Centre for Disease Control (NCDC), University of Cambridge - Department of Zoology, University College London - Institute for Global Health, Bavarian Nordic A/S, Government of the United States of America - Division of High Consequence Pathogens and Pathology, University of Cambridge - Department of Zoology, Forge Veterinary Centre, Niger Delta University (NDU), Nigeria Centre for Disease Control (NCDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Bavarian Nordic, Inc., Government of the United Kingdom - SO1 Public Health and Health Protection, University of California, Los Angeles (UCLA) - Department of Epidemiology, Government of the United Kingdom - Defence Science & Technology Laboratory and Government of the United Kingdom - National Health Service (NHS)
Downloads 54 (743,061)
Citation 6

Abstract:

Loading...

smallpox; monkeypox; orthopox; eradication; Risk; epidemiology; vaccines